Patents-Review.com
ClassID:

97113 ⎘

C07K16/1027 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus Paramyxoviridae, e.g. respiratory syncytial virus

Recent Application in this class:
#1
20260028391
2026-01-29

BROADLY NEUTRALIZING ANTIBODIES AGAINST RSV AND MPV PARAMYXOVIRUSES

 #2
20250388654
2025-12-25

ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS

 #3
20250388653
2025-12-25

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

 #4
20250375514
2025-12-11

METHODS OF INHIBITING PARAMYXOVIRIDAE FUSION TO A TARGET CELL

 #5
20250353920
2025-11-20

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

 #6
20250340622
2025-11-06

PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT INFECTION WITH NIRSEVIMAB

 #7
20250313612
2025-10-09

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

 #8
20250296987
2025-09-25

RSV/HMPV CROSS-REACTIVE ANTIBODIES

 #9
20250296982
2025-09-25

ENGINEERED POLYPEPTIDES AND USES THEREOF

 #10
20250223572
2025-07-10

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

 #11
20250206808
2025-06-26

Antibodies Against Henipaviruses

 #12
20250179153
2025-06-05

RSV-SPECIFIC ANTIBODIES AND FUNCTIONAL PARTS THEREOF

 #13
20250129128
2025-04-24

RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

 #14
20250121221
2025-04-17

BETACORONA VIRUS mRNA VACCINES

 #15
20250121220
2025-04-17

BETACORONAVIRUS mRNA VACCINES

 #16
20250099569
2025-03-27

RESPIRATORY SYNCYTIAL VIRUS VACCINE

 #17
20250082751
2025-03-13

COMPOSITIONS AND METHODS FOR INHIBITING PATHOGEN INFECTION

 #18
20250066729
2025-02-27

Systems and Methods Incorporating Modified T-Cells

 #19
20250051478
2025-02-13

scFv and Antibodies with Reduced Multimerisation

 #20
20250042977
2025-02-06

C-BASED SINGLE DOMAIN ANTIBODY FOR NEUTRALIZING RESPIRATORY SYNCYTIAL VIRUS AND APPLICATION THEREOF

 #21
20250026815
2025-01-23

ANTI-RSV ANTIBODY AND APPLICATION THEREOF

 #22
20250011401
2025-01-09

OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTS

 #23
20240417447
2024-12-19

DOSAGE REGIMENS FOR AND COMPOSITIONS INCLUDING ANTI-RSV ANTIBODIES

 #24
20240409621
2024-12-12

ANTIBODY FOR RECOGNIZING RSV PRE-F PROTEIN AND USE THEREOF

 #25
20240409620
2024-12-12

DESIGN AND APPLICATION OF FULLY HUMAN ANTIBODY FOR NEUTRALIZING RESPIRATORY SYNCYTIAL VIRUS

 #26
20240391962
2024-11-28

Respiratory syncytial virus (RSV) vaccine

 #27
20240366972
2024-11-07

Chimeric Antigen Receptor-Modified NK-92 Cells

 #28
20240366749
2024-11-07

COMBINATION HMPV/RSV RNA VACCINES

 #29
20240366748
2024-11-07

Betacoronavirus RNA vaccines

 #30
20240350617
2024-10-24

COMBINATION HMPV/RSV RNA VACCINES

 #31
20240335526
2024-10-10

COMBINATION HMPV/RSV RNA VACCINES

 #32
20240294614
2024-09-05

ANTI-HENIPAVIRUS MONOCLONAL ANTIBODY HAVING BROAD SPECTRUM NEUTRALIZATION ACTIVITY AND USE THEREOF

 #33
20240294579
2024-09-05

Respiratory syncytial virus (RSV) vaccine

 #34
20240262894
2024-08-08

ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS AND USE THEREOF

 #35
20240247052
2024-07-25

ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS

 #36
20240238623
2024-07-18

Chimeric Antigen Receptor-Modified NK-92 Cells

 #37
20240228597
2024-07-11

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, METHODS OF THEIR GENERATION AND USE

 #38
20240158480
2024-05-16

ANTI-NIPAH VIRUS MONOCLONAL ANTIBODY HAVING NEUTRALIZATION ACTIVITY AND APPLICATION

 #39
20240150444
2024-05-09

PROTECTIVE ANTIBODIES AGAINST RESPIRATORY VIRAL INFECTIONS

 #40
20240150443
2024-05-09

ANTIVIRALS AGAINST MEASLES VIRUS

 #41
20240150414
2024-05-09

CONFORMATIONAL EPITOPES IN RESPIRATORY SYNCYTIAL VIRUS G PROTEIN CENTRAL CONSERVED REGION

 #42
20240141022
2024-05-02

ANTIBODY-CYTOKINS ENGRAFTED PROTEINS AND METHODS OF US IN THE TREATMENT OF CANCER

 #43
20240139306
2024-05-02

METHODS AND COMPOSITIONS FOR DETECTING AND PRODUCING PORCINE MORBILLIVIRUS AND VACCINES THEREOF

 #44
20240124612
2024-04-18

MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES

 #45
20240101648
2024-03-28

ANTIBODIES AGAINST RESPIRATORY SYNCYTIAL VIRUS, HUMAN METAPNEUMOVIRUS AND PNEUMONIA VIRUS OF MICE AND METHODS OF USING THE SAME

 #46
20240059763
2024-02-22

RESPIRATORY SYNCYTIAL VIRUS-SPECIFIC BINDING MOLECULE

 #47
20240052013
2024-02-15

SYSTEMS AND METHODS TO LINK CD40 SIGNALING TO ANTIGEN BINDING

 #48
20240043550
2024-02-08

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

 #49
20240043509
2024-02-08

Biological Therapeutics for Infection-Relating Disorders or Conditions

 #50
20240043503
2024-02-08

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY

 #51
20240034773
2024-02-01

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

 #52
20240034772
2024-02-01

ANTIBODIES BINDING TO F-PROTEIN OF METAPNEUMOVIRUS AND USES THEREOF

 #53
20240016933
2024-01-18

Methods of Anchoring or Reconstituting Active Molecules on Metabolically Labeled Cells

 #54
20240011981
2024-01-11

Two-Dimensional Multiplex Chromatography Test Card

 #55
20240002449
2024-01-04

Respiratory syncytial virus (RSV) vaccine

 #56
20230399383
2023-12-14

ANTI-RSV MONOCLONAL ANTIBODY FORMULATION

 #57
20230390335
2023-12-07

SYNTHETIC ANTIGENS AS CHIMERIC ANTIGEN RECEPTOR (CAR) LIGANDS AND USES THEREOF

 #58
20230382954
2023-11-30

RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

 #59
20230365695
2023-11-16

COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF

 #60
20230365660
2023-11-16

RSV-specific antibodies and functional parts thereof

 #61
20230357371
2023-11-09

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

 #62
20230357370
2023-11-09

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

 #63
20230357369
2023-11-09

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

 #64
20230348575
2023-11-02

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

 #65
20230348574
2023-11-02

RSV F protein compositions and methods for making same

 #66
20230303669
2023-09-28

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

 #67
20230303668
2023-09-28

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

 #68
20230293731
2023-09-21

RNA ENCODING AN ANTIBODY

 #69
20230250159
2023-08-10

SYSTEMS AND METHODS TO PRODUCE B CELLS GENETICALLY MODIFIED TO EXPRESS SELECTED ANTIBODIES

 #70
20230235092
2023-07-27

ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

 #71
20230212269
2023-07-06

Antibody neutralizing human respiratory syncytial virus

 #72
20230192822
2023-06-22

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

 #73
20230167178
2023-06-01

Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof

 #74
20230116380
2023-04-13

LONG-ACTING GM-CSF AND METHODS OF USE

 #75
20230114180
2023-04-13

RESPIRATORY SYNCYTIAL VIRUS VACCINE

 #76
20230085439
2023-03-16

ANTIBODIES THAT BIND HUMAN METAPNEUMOVIRUS FUSION PROTEIN AND THEIR USE

 #77
20230073075
2023-03-09

HUMAN HENDRA VIRUS AND NIPAH VIRUS ANTIBODIES AND METHODS OF USE THEREFOR

 #78
20230034964
2023-02-02

Formulations for Enteric Delivery of Therapeutic Agents

 #79
20230003724
2023-01-05

IMMUNOASSAY METHOD AND IMMUNOASSAY APPARATUS

 #80
20230002479
2023-01-05

ANTI-RS VIRUS-RECOGNIZING ANTIBODY, AND IMMUNOASSAY METHOD AND IMMUNOASSAY APPARATUS USING THE ANTIBODY

 #81
20220403010
2022-12-22

ANTI-RS VIRUS N PROTEIN-RECOGNIZING ANTIBODY, AND IMMUNOASSAY METHOD AND IMMUNOASSAY APPARATUS USING THE ANTIBODY

 #82
20220403008
2022-12-22

Compositions and methods for the treatment of immunodeficiency

 #83
20220401485
2022-12-22

Chimeric antigen receptor-modified NK-92 cells

 #84
20220372115
2022-11-24

RSV F protein compositions and methods for making same

 #85
20220340645
2022-10-27

RSV F protein compositions and methods for making same

 #86
20220323460
2022-10-13

Combination pharmaceutical agents as RSV inhibitors

 #87
20220267740
2022-08-25

Paramyxovirus virus-like particles as protein delivery vehicles

 #88
20220213177
2022-07-07

RSV F protein compositions and methods for making same

 #89
20220204593
2022-06-30

DOSAGE REGIMENS FOR AND COMPOSITIONS INCLUDING ANTI-RSV ANTIBODIES

 #90
20220195016
2022-06-23

BIOLOGICAL AND SYNTHETIC MOLECULES INHIBITING RESPIRATORY SYNCYTIAL VIRUS INFECTION

 #91
20220185903
2022-06-16

Novel bispecific binding molecule and drug conjugate thereof

 #92
20220162567
2022-05-26

PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES

 #93
20220144922
2022-05-12

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

 #94
20220098285
2022-03-31

RSV-specific antibodies and functional parts thereof

 #95
20220089697
2022-03-24

Monoclonal antibody or antigen binding fragment thereof that binds to the L protein of the human parainfluenza virus (PIV); method and kit for detecting PIV

 #96
20220089652
2022-03-24

Stabilized soluble pre-fusion RSV F proteins

 #97
20220048969
2022-02-17

Relaxin immunoglobulin fusion proteins and methods of use

 #98
20210347862
2021-11-11

Specific monoclonal antibody against the N antigen of human respiratory syncytial virus (hRSV) useful for treating infection, detection thereof and diagnosis

 #99
20210324052
2021-10-21

FORMULATIONS OF ANTI-RSV ANTIBODIES AND METHODS OF USE THEREOF

 #100
20210317191
2021-10-14

Anti-RSV monoclonal antibody formulation

 #101
20210292395
2021-09-23

ANTIGEN PURIFICATION METHOD

 #102
20210277094
2021-09-09

RSV-SPECIFIC BINDING MOLECULE

 #103
20210269771
2021-09-02

GENETIC ENGNEERING OF B CELL RECEPTORS AND USES THEREOF IN ANTIGEN-INDUCED ANTIBODY SECRETION

 #104
20210261627
2021-08-26

Respiratory syncytial virus (RSV) vaccine

 #105
20210260116
2021-08-26

Chimeric antigen receptor-modified NK-92 cells

 #106
20210230288
2021-07-29

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

 #107
20210230230
2021-07-29

Soluble Forms of Hendra and Nipah Virus G Glycoprotein

 #108
20210198344
2021-07-01

Systems and methods to produce B cells genetically modified to express selected antibodies

 #109
20210188951
2021-06-24

Antibody neutralizing human respiratory syncytial virus

 #110
20210188950
2021-06-24

Antibodies against F glycoprotein of Hendra and Nipah viruses

 #111
20210188949
2021-06-24

Antibodies that potently neutralize RSV and uses thereof

 #112
20210188947
2021-06-24

Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

 #113
20210171630
2021-06-10

Bispecific CD16-binding molecules and their use in the treatment of disease

 #114
20210130441
2021-05-06

Compositions and methods for the treatment of immunodeficiency

 #115
20210115114
2021-04-22

Antibodies that neutralize RSV, MPV and PVM and uses thereof

 #116
20210106673
2021-04-15

RESPIRATORY SYNCYTIAL VIRUS VACCINE

 #117
20210095021
2021-04-01

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

 #118
20210070844
2021-03-11

Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV

 #119
20210061889
2021-03-04

Compositions and methods for inhibiting pathogen infection

 #120
20210047390
2021-02-18

NUCLEIC ACID ANTIBODY CONSTRUCTS FOR USE AGAINST RESPIRATORY SYNCYTIAL VIRUS

 #121
20210023195
2021-01-28

Compositions and methods for vaccination against respiratory syncytial virus infection

 #122
20210002381
2021-01-07

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

 #123
20210002355
2021-01-07

Compositions and methods for inhibiting pathogen infection

 #124
20200405844
2020-12-31

Combination HMPV/RSV RNA vaccines

 #125
20200399718
2020-12-24

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #126
20200392209
2020-12-17

Stabilized liquid anti-RSV antibody formulations

 #127
20200362046
2020-11-19

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

 #128
20200347120
2020-11-05

Dosage regimens for and compositions including anti-RSV antibodies

 #129
20200339667
2020-10-29

Anti-RSV monoclonal antibody formulation

 #130
20200331989
2020-10-22

RSV-specific antibodies and functional parts thereof

 #131
20200325220
2020-10-15

ANTIBODIES WITH FUNCTIONAL DOMAINS IN THE ELBOW REGION BETWEEN VARIABLE AND CONSTANT DOMAIN

 #132
20200325213
2020-10-15

RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR PRODUCING THEM

 #133
20200317754
2020-10-08

RSV-SPECIFIC BINDING MOLECULE

 #134
20200282046
2020-09-10

Betacoronavirus mRNA vaccine

 #135
20200277358
2020-09-03

ENGINEERED POLYPEPTIDES AND USES THEREOF

 #136
20200270353
2020-08-27

Coiled coil immunoglobulin fusion proteins and compositions thereof

 #137
20200270334
2020-08-27

Antibody-IL2 engrafted proteins and methods of use in the treatment of cancer

 #138
20200261584
2020-08-20

STABILIZED PROTEIN GEL PREPARATION

 #139
20200246449
2020-08-06

INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME

 #140
20200239550
2020-07-30

Anti-respiratory syncytial virus antibodies, methods of their generation and use

 #141
20200223934
2020-07-16

De novo binding domain containing polypeptides and uses thereof

 #142
20200223906
2020-07-16

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

 #143
20200216559
2020-07-09

Heterodimeric antibodies that bind CD3 and PSMA

 #144
20200197510
2020-06-25

Betacoronavirus mRNA vaccine

 #145
20200172600
2020-06-04

RSV F protein compositions and method for making same

 #146
20200140964
2020-05-07

Virus causing respiratory tract illness in susceptible mammals

 #147
20200129608
2020-04-30

Respiratory syncytial virus vaccine

 #148
20200123623
2020-04-23

Immunogenic Cedar Virus compositions

 #149
20200123235
2020-04-23

BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES

 #150
20200123233
2020-04-23

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #151
20200113974
2020-04-16

Antibody-cytokine engrafted proteins and methods of use for immune related disorders

 #152
20200102374
2020-04-02

Immunoglobulin single variable domain antibody against RSV prefusion F protein

 #153
20200071423
2020-03-05

Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties

 #154
20200024672
2020-01-23

METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE FORMULATIONS AND AS VECTORS FOR EXPRESSION OF ANTIGENIC SEQUENCES

 #155
20200023076
2020-01-23

RNA encoding an antibody

 #156
20200002407
2020-01-02

Antibody neutralizing human respiratory syncytial virus

 #157
20190375825
2019-12-12

Antibodies that potently neutralize RSV and uses thereof

 #158
20190367586
2019-12-05

Antibodies to human respiratory syncytial virus protein F pre-fusion conformation and methods of use therefor

 #159
20190338253
2019-11-07

Paramyxovirus virus-like particles as protein delivery vehicles

 #160
20190330277
2019-10-31

Recombinant prefusion RSV F proteins and uses thereof

 #161
20190284260
2019-09-19

RNA-CODED ANTIBODY

 #162
20190270792
2019-09-05

Biological therapeutics for infection-relating disorders or conditions

 #163
20190263882
2019-08-29

Relaxin immunoglobulin fusion proteins and methods of use

 #164
20190256581
2019-08-22

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

 #165
20190256580
2019-08-22

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

 #166
20190240317
2019-08-08

HPIV3 RNA vaccines

 #167
20190240316
2019-08-08

HUMAN RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES AND METHODS OF USE THEREFOR

 #168
20190216918
2019-07-18

Recombinant mumps virus vaccine

 #169
20190216917
2019-07-18

hMPV RNA vaccines

 #170
20190192535
2019-06-27

Combination pharmaceutical agents as RSV inhibitors

 #171
20190153073
2019-05-23

ANTIBODIES THAT NEUTRALIZE RSV, MPV AND PVM AND USES THEREOF

 #172
20190144508
2019-05-16

Respiratory syncytial virus (RSV) vaccine

 #173
20190135876
2019-05-09

Conformational epitopes in respiratory syncytial virus G protein central conserved region

 #174
20190127447
2019-05-02

TREATMENT OF RSV INFECTION

 #175
20190119762
2019-04-25

Virus causing respiratory tract illness in susceptible mammals

 #176
20190119330
2019-04-25

Stabilized soluble pre-fusion RSV F proteins

 #177
20190106482
2019-04-11

RSV-specific antibodies and functional parts thereof

 #178
20190091335
2019-03-28

ANTIBODY FORMULATIONS CONTAINING AMINO ACIDS

 #179
20190083605
2019-03-21

RESPIRATORY SYNCYTIAL VIRUS VACCINE

 #180
20190077847
2019-03-14

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #181
20190054084
2019-02-21

Combination products for the treatment of RSV

 #182
20190040120
2019-02-07

RSV-specific binding molecule

 #183
20190031741
2019-01-31

Human Antibodies to Respiratory Syncytial Virus F Protein and Methods of Use Thereof

 #184
20190031721
2019-01-31

Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof

 #185
20190031719
2019-01-31

Soluble Forms of Hendra and Nipah Virus G Glycoprotein

 #186
20190023769
2019-01-24

Compositions and methods for inhibiting pathogen infection

 #187
20190002538
2019-01-03

Antibodies that potently neutralize RSV and uses thereof

 #188
20190002537
2019-01-03

METHOD FOR ENRICHING A PREPARATION OF IMMUNOGLOBULINS WITH ANTI RSV IMMUNOGLOBULINS AND PREPARATION ENRICHED IN THIS WAY

 #189
20180346605
2018-12-06

Engineered multispecific antibodies and other multimeric proteins with asymmetrical CH2-CH3 region mutations

 #190
20180327800
2018-11-15

MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS

 #191
20180327484
2018-11-15

RSV-specific binding molecules and means for producing them

 #192
20180327483
2018-11-15

Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV

 #193
20180326045
2018-11-15

Combination PIV3/hMPV RNA vaccines

 #194
20180298081
2018-10-18

Antibodies against F glycoprotein of Hendra and Nipah viruses

 #195
20180264103
2018-09-20

Fully human antibody against respiratory syncytical virus

 #196
20180258178
2018-09-13

Molecules with Reduced Effector Function and Extended Half-Lives, Compositions, and Uses Thereof

 #197
20180258159
2018-09-13

Compositions and methods for the treatment of immunodeficiency

 #198
20180251563
2018-09-06

De novo binding domain containing polypeptides and uses thereof

 #199
20180251526
2018-09-06

Anti-RSV monoclonal antibody formulation

 #200
20180251521
2018-09-06

De novo binding domain containing polypeptides and uses thereof

 #201
20180230202
2018-08-16

Stabilized liquid anti-RSV antibody formulations

 #202
20180216200
2018-08-02

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #203
20180215810
2018-08-02

Antibody neutralizing human respiratory syncytial virus

 #204
20180215809
2018-08-02

Antibody neutralizing human respiratory syncytial virus

 #205
20180215808
2018-08-02

Antibody neutralizing human respiratory syncytial virus

 #206
20180209983
2018-07-26

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

 #207
20180207145
2018-07-26

PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES

 #208
20180179266
2018-06-28

Immunoglobulin single variable domain antibody against RSV prefusion F protein

 #209
20180155423
2018-06-07

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

 #210
20180105581
2018-04-19

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

 #211
20180098946
2018-04-12

Formulations for enteric delivery of therapeutic agents

 #212
20180086818
2018-03-29

Compositions and methods for the treatment of immunodeficiency

 #213
20180057894
2018-03-01

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #214
20180057893
2018-03-01

Virus causing respiratory tract illness in susceptible mammals

 #215
20180037634
2018-02-08

Engineered polypeptides and uses thereof

 #216
20180030119
2018-02-01

Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)

 #217
20180016306
2018-01-18

Mutant immunoglobulin K chain variable region-binding peptide

 #218
20170343546
2017-11-30

Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV) and use thereof in a diagnostic method

 #219
20170342134
2017-11-30

RSV G protein specific antibodies

 #220
20170334948
2017-11-23

LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV

 #221
20170333812
2017-11-23

Manufacturing method

 #222
20170327535
2017-11-16

Affinity separation matrix for purifying protein containing immunoglobulin K chain variable region

 #223
20170320947
2017-11-09

Heterodimeric antibodies that bind CD3 and PSMA

 #224
20170304566
2017-10-26

Methods of treating RSV infections

 #225
20170304565
2017-10-26

Inhalation device for use in aerosol therapy of respiratory diseases

 #226
20170267780
2017-09-21

MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES

 #227
20170253647
2017-09-07

BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES

 #228
20170233449
2017-08-17

Fusions of antibodies to CD38 and attenuated interferon alpha

 #229
20170218030
2017-08-03

Respiratory syncytial virus (RSV) vaccine

 #230
20170183747
2017-06-29

Virus causing respiratory tract illness in susceptible mammals

 #231
20170175086
2017-06-22

Paramyxovirus virus-like particles as protein delivery vehicles

 #232
20170174728
2017-06-22

Soluble forms of Hendra and Nipah virus G glycoprotein

 #233
20170137899
2017-05-18

strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #234
20170121394
2017-05-04

Antibody neutralizing human respiratory syncytial virus

 #235
20170121393
2017-05-04

Antibodies that neutralize RSV, MPV and PVM and uses thereof

 #236
20170100385
2017-04-13

PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES

 #237
20170029488
2017-02-02

Human antibodies to respiratory syncytial virus F protein and methods of use thereof

 #238
20170021114
2017-01-26

Nebultzation of immunoglobulin

 #239
20160368971
2016-12-22

IgA multi-specific binding molecules

 #240
20160362755
2016-12-15

Cedar virus and methods of use

 #241
20160355572
2016-12-08

System, apparatus and method for biomolecules production

 #242
20160347827
2016-12-01

Antibodies against F glycoprotein of Hendra and Nipah viruses

 #243
20160346379
2016-12-01

Respiratory syncytial virus vaccine

 #244
20160340435
2016-11-24

Molecular constructs for treating central nervous system diseases

 #245
20160340427
2016-11-24

Molecular constructs for treating infectious diseases

 #246
20160340414
2016-11-24

RSV-SPECIFIC ANTIBODIES AND FUNCTIONAL PARTS THEREOF

 #247
20160339116
2016-11-24

Molecular constructs with targeting and effector moieties for treating infectious diseases

 #248
20160339115
2016-11-24

Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimod

 #249
20160339111
2016-11-24

Peptide core-based multi-arm linkers for treating infectious diseases

 #250
20160339110
2016-11-24

Peptide core-based multi-arm linkers for treating central nervous system diseases

 #251
20160339109
2016-11-24

Peptide core-based multi-arm linkers and their applications

 #252
20160304565
2016-10-20

Recombinant respiratory syncytial virus G protein fragments

 #253
20160280799
2016-09-29

Pulmonary administration of immunoglobulin single variable domains and constructs thereof

 #254
20160272697
2016-09-22

Neutralizing Antibodies to Nipah and Hendra Virus

 #255
20160251412
2016-09-01

RSV-specific binding molecule

 #256
20160244850
2016-08-25

Virus causing respiratory tract illness in susceptible mammals

 #257
20160244509
2016-08-25

RSV-specific binding molecules and means for producing them

 #258
20160213778
2016-07-28

Canine health product containing antibodies against canine parvovirus type 2

 #259
20160200802
2016-07-14

Antibodies that potently neutralize RSV and uses thereof

 #260
20160194383
2016-07-07

Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use

 #261
20160194382
2016-07-07

Means and methods for producing high affinity antibodies

 #262
20160185840
2016-06-30

RNA-CODED ANTIBODY

 #263
20160168207
2016-06-16

Respiratory syncytial virus (RSV) vaccine

 #264
20160160258
2016-06-09

MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS

 #265
20160159920
2016-06-09

Coiled coil immunoglobulin fusion proteins and compositions thereof

 #266
20160159886
2016-06-09

Stabilized liquid anti-RSV antibody formulations

 #267
20160152693
2016-06-02

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #268
20160145322
2016-05-26

Human antibodies binding to RSV G proteins

 #269
20160145321
2016-05-26

Human antibodies binding to RSV G protein

 #270
20160139125
2016-05-19

Immunochromatography device for detecting RSV

 #271
20160122418
2016-05-05

Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)

 #272
20160115221
2016-04-28

Compositions and methods for the treatment of immunodeficiency

 #273
20160114037
2016-04-28

Compositions and methods for the treatment of immunodeficiency

 #274
20160054321
2016-02-25

Methods for detecting human metapneumovirus

 #275
20160031972
2016-02-04

Epitope of RSV fusion protein and antibody recognizing the same

 #276
20160024186
2016-01-28

Biological therapeutics for infection-relating disorders or conditions

 #277
20160017038
2016-01-21

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

 #278
20160009810
2016-01-14

Methods of administering IgG1 antibodies and methods of suppressing angiogenesis

 #279
20160009760
2016-01-14

Ligands for antibody and Fc-fusion protein purification by affinity chromotography IV

 #280
20150366960
2015-12-24

Respiratory syncytial virus F protein epitopes

 #281
20150328306
2015-11-19

Antibodies against and methods for producing vaccines for respiratory syncytial virus

 #282
20150322137
2015-11-12

HUMAN ANTIBODY SPECIFIC TO HUMAN METAPNEUMOVIRUS, OR ANTIGEN-BINDING FRAGMENT THEREOF

 #283
20150306208
2015-10-29

Soluble forms of hendra and nipah virus G glycoprotein

 #284
20150284447
2015-10-08

METHOD OF ISOLATING SYNAGIS(R) IN THE ABSENCE OF BENZONASE

 #285
20150259401
2015-09-17

Antibodies with improved half-life in ferrets

 #286
20150210777
2015-07-30

GLYCOPROTEIN

 #287
20150191702
2015-07-09

Paramyxovirus and Methods of Use

 #288
20150125444
2015-05-07

Molecules with reduced effector function and extended half-lives, compositions, and uses thereof

 #289
20150118233
2015-04-30

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

 #290
20150104446
2015-04-16

GENETIC AND ENVIRONMENTAL MARKERS TO IDENTIFY INFANTS AT RISK FOR SEVERE LUNG DISEASE

 #291
20150086544
2015-03-26

Stabilized liquid anti-RSV antibody formulations

 #292
20150004155
2015-01-01

RSV G protein specific antibodies

 #293
20140377279
2014-12-25

RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR PRODUCING THEM

 #294
20140370497
2014-12-18

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #295
20140363427
2014-12-11

Anti-human respiratory syncytial virus (RSV) antibodies and methods of use

 #296
20140348858
2014-11-27

Monoclonal antibodies specific for the M2-1 antigen of respiratory syncytial virus (RSV)

 #297
20140329276
2014-11-06

Methods for increasing N-glycan occupancy and reducing production of hybrid N-glycans in pichia pastoris strains lacking ALG3 expression

 #298
20140295409
2014-10-02

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

 #299
20140288267
2014-09-25

COMPOSITIONS AND METHODS FOR MODULATING RSV INFECTION AND IMMUNITY

 #300
20140271653
2014-09-18

Human antibodies to respiratory syncytial virus F protein and methods of use thereof